P Grozea

2.1k total citations · 1 hit paper
28 papers, 1.6k citations indexed

About

P Grozea is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, P Grozea has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pathology and Forensic Medicine and 7 papers in Genetics. Recurrent topics in P Grozea's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lung Cancer Treatments and Mutations (7 papers). P Grozea is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lung Cancer Treatments and Mutations (7 papers). P Grozea collaborates with scholars based in United States and United Kingdom. P Grozea's co-authors include Henry E. Wilson, Charles A. Coltman, Ronald L. Stephens, Arthur Haut, Stephen E. Jones, Thomas E. Moon, Eugene M. McKelvey, Dennis O. Dixon, Siân Jones and Robert W. Talley and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

P Grozea

27 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

1976 625 citations Eugene M. McKelvey, Jeffrey A. Gottlieb et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Grozea United States	12	1.1k	889	385	366	337	28	1.6k
B. Vaughan Hudson United Kingdom	24	1.5k 1.5×	830 0.9×	451 1.2×	377 1.0×	522 1.5×	36	1.9k
R S Cox United States	20	1.0k 1.0×	712 0.8×	567 1.5×	334 0.9×	747 2.2×	25	2.1k
S.B. Sutcliffe United Kingdom	9	1.3k 1.3×	663 0.7×	313 0.8×	441 1.2×	400 1.2×	12	1.7k
Patrizio Mazza Italy	22	1.1k 1.0×	680 0.8×	516 1.3×	387 1.1×	248 0.7×	98	1.8k
A.M. Jelliffe United Kingdom	18	1.3k 1.2×	751 0.8×	522 1.4×	247 0.7×	391 1.2×	54	1.8k
C. Portlock United States	21	1.1k 1.0×	732 0.8×	438 1.1×	261 0.7×	367 1.1×	36	1.6k
CW Berard United States	22	1.2k 1.1×	672 0.8×	428 1.1×	417 1.1×	228 0.7×	34	1.7k
Kaplan Hs United States	17	1.1k 1.0×	498 0.6×	345 0.9×	333 0.9×	396 1.2×	47	1.4k
W S Velasquez United States	16	845 0.8×	670 0.8×	367 1.0×	238 0.7×	229 0.7×	17	1.3k
DC Linch United Kingdom	19	949 0.9×	720 0.8×	397 1.0×	256 0.7×	174 0.5×	37	1.5k

Countries citing papers authored by P Grozea

Since Specialization

Citations

This map shows the geographic impact of P Grozea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Grozea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Grozea more than expected).

Fields of papers citing papers by P Grozea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Grozea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Grozea. The network helps show where P Grozea may publish in the future.

Co-authorship network of co-authors of P Grozea

This figure shows the co-authorship network connecting the top 25 collaborators of P Grozea. A scholar is included among the top collaborators of P Grozea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Grozea. P Grozea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grozea, P, John J. Crowley, Laura Kingsbury, et al.. (1997). Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.. PubMed. 80(6). 1029–33. 7 indexed citations

Grozea, P, John J. Crowley, Laura Kingsbury, et al.. (1997). Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma. Cancer. 80(6). 1029–1033. 5 indexed citations

Mansfield, Carl M., Carol J. Fabian, Steve Dahlberg, et al.. (1991). Radiation consolidation following MOP-BAP for stages III & IV Hodgkin's disease, A randomized Southwest Oncology study. International Journal of Radiation Oncology*Biology*Physics. 21. 191–191. 5 indexed citations

Mansfield, Carl M., Carol J. Fabian, Stephen Jones, et al.. (1990). Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease: A southwest oncology group study. Cancer. 66(11). 2295–2299. 30 indexed citations

Vaughn, Clarence B., Stephanie Green, Robert M. OʼBryan, et al.. (1988). VP‐16 + adriamycin vs. Adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: A southwest oncology group study. Medical and Pediatric Oncology. 16(5). 312–319. 14 indexed citations

Kies, M.S., Joaquin G. Mira, John J. Crowley, et al.. (1987). Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.. Journal of Clinical Oncology. 5(4). 592–600. 140 indexed citations

Dixon, Dennis O., Barbara A. Neilan, Siân Jones, et al.. (1986). Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.. Journal of Clinical Oncology. 4(3). 295–305. 300 indexed citations

Panettiere, Frank J., Noboru Oishi, Harmon J. Eyre, et al.. (1986). Bisantrene hydrochloride in gastric adenocarcinoma: A southwest oncology group study. Medical and Pediatric Oncology. 14(2). 78–80. 4 indexed citations

Slease, R B, et al.. (1986). Thyroid Lymphoma with gastrointestinal involvement: Report of three cases. American Journal of Hematology. 21(4). 357–365. 7 indexed citations

10.

Weick, James K., Siân Jones, P Grozea, Carol J. Fabian, & Dennis O. Dixon. (1984). Vindesine, carmustine, doxorubicin, and prednisone (EBAP) in recurrent lymphomas: a Southwest Oncology Group study.. PubMed. 68(7-8). 963–7. 7 indexed citations

11.

Gagliano, Robert G., Richard Stephens, J J Costanzi, et al.. (1984). Randomized trial of hexamethylmelamine versus 5-FU, doxorubicin, and cyclophosphamide (FAC) in advanced transitional cell bladder carcinoma: a Southwest Oncology Group study.. PubMed. 68(7-8). 1025–6. 9 indexed citations

12.

Livingston, Robert B., Ronald L. Stephens, John D. Bonnet, P Grozea, & Daniel E. Lehane. (1984). Long-term survival and toxicity in small cell lung cancer. The American Journal of Medicine. 77(3). 415–417. 64 indexed citations

13.

Jones, Stephen E., Arthur Haut, James K. Weick, et al.. (1983). Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-bleomycin in the management of advanced Hodgkin-s disease a southwest oncology group study. Cancer. 51(8). 1339–1347. 36 indexed citations

14.

Jones, Stephen E., P Grozea, Earl N. Metz, et al.. (1983). Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy: A southwest oncology group study. Cancer. 51(6). 1083–1090. 47 indexed citations

15.

Murray, James L., et al.. (1983). Inefficacy of sc Corynebacterium parvum in stage I malignant melanoma: preliminary results of a single-institution pilot study.. PubMed. 67(2). 191–2. 4 indexed citations

16.

Chan, Wing C., et al.. (1979). Mycosis fungoides and Hodgkin's disease occurring in the same patient. Report of three cases. Cancer. 44(4). 1408–1413. 56 indexed citations

17.

Jones, Stephen E., P Grozea, Earl N. Metz, et al.. (1979). Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma.A southwest oncology group study. Cancer. 43(2). 417–425. 115 indexed citations

18.

Grozea, P, et al.. (1979). Chemotherapy versus chemotherapy plus radiotherapy for stage IIIA, IIIB Hodgkin's disease. A southwest oncology group study. International Journal of Radiation Oncology*Biology*Physics. 5. 138–138. 1 indexed citations

19.

McKelvey, Eugene M., Jeffrey A. Gottlieb, Henry E. Wilson, et al.. (1976). Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer. 38(4). 1484–1493. 625 indexed citations breakdown →

20.

Palmieri, Genaro M. A., et al.. (1972). EFFECT OF CALCITONIN AND VITAMIN D ON RADIOLOGICAL CHANGES IN PAGET'S DISEASE. The Lancet. 300(7789). 1250–1250. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact